Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Gunilla Telg"'
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Background Short-acting β2-agonist (SABA) overuse has been associated with an increased risk of exacerbations in asthma; however, less is known about SABA use in COPD. Our aim was to describe SABA use and investigate potential associations between h
Externí odkaz:
https://doaj.org/article/9983fb1ed732422e9b220d709f12d380
Autor:
Laurits Frøssing, Ditte K. Klein, Morten Hvidtfeldt, Nicolai Obling, Gunilla Telg, Jonas S. Erjefält, Uffe Bodtger, Celeste Porsbjerg
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Background Type 2 (T2) high asthma is recognised as a heterogenous entity consisting of several endotypes; however, the prevalence and distribution of the T2 biomarkers in the general asthma population, across asthma severity, and across compartments
Externí odkaz:
https://doaj.org/article/ae664511f5b442cab827ec26286a8394
Autor:
Lauri Lehtimäki, Monica Arvidsson, Bora Erdemli, Cassandra Nan, Tra-My Nguyen, Aditya Samant, Gunilla Telg
Publikováno v:
European Clinical Respiratory Journal, Vol 9, Iss 1 (2022)
Oral corticosteroids (OCS) are often prescribed to patients with asthma that remains uncontrolled with maintenance therapy. We performed a real-world analysis to describe the geographic distributions of patients with asthma and OCS dispensed in Nordi
Externí odkaz:
https://doaj.org/article/55302edd769542248cdcdaa67dbfa4fb
Autor:
Sanna Toppila‐Salmi, Jenni Hällfors, Juhani Aakko, Bettina Mannerström, Kaisa Nieminen, Gunilla Telg, Lauri Lehtimäki
Publikováno v:
Clinical and Translational Allergy, Vol 12, Iss 10, Pp n/a-n/a (2022)
Abstract Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is commonly associated with asthma. Treatment of CRSwNP includes intranasal and systemic corticosteroids, with non‐responsive patients commonly considered for endoscopic sinus su
Externí odkaz:
https://doaj.org/article/c3140aec761e4fa78571fa63150a1d58
Autor:
Arja Viinanen, Juhani Aakko, Mariann I. Lassenius, Gunilla Telg, Kaisa Nieminen, Saara Kaijala, Lauri Lehtimäki, Hannu Kankaanranta
Publikováno v:
Biomolecules, Vol 13, Iss 7, p 1118 (2023)
We investigated the stability of T2 low status, based on low levels of T2 biomarkers, and exacerbation rates in T2 low and non-T2 low asthma from clinical retrospective data of severe uncontrolled asthma patients. Knowledge of the T2 low biomarker pr
Externí odkaz:
https://doaj.org/article/9bf38237e3014a21b4dd18bf700cf616
Publikováno v:
European Clinical Respiratory Journal, Vol 8, Iss 1 (2021)
Background: Severe asthma has an acknowledged impact on health-related quality of life (HRQOL) and is associated with substantial health care costs. This study aimed to investigate the patients’ own experiences of the disease, perceptions of HRQOL,
Externí odkaz:
https://doaj.org/article/5b2d01bbcdfd470188d06dbfdd8e1585
Autor:
Christer Janson, Karin Lisspers, Björn Ställberg, Gunnar Johansson, Gunilla Telg, Marcus Thuresson, Helene Nordahl Christensen, Kjell Larsson
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Patients with severe uncontrolled asthma may receive oral corticosteroid (OCS) treatment regularly. The present study investigated the health care resource utilization and cost in regularly OCS treated Swedish asthma patients. Met
Externí odkaz:
https://doaj.org/article/400e18be072a439698892bf0401e35a1
Autor:
Kjell Larsson, Björn Ställberg, Karin Lisspers, Gunilla Telg, Gunnar Johansson, Marcus Thuresson, Christer Janson
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Severe and uncontrolled asthma is associated with increased risk of exacerbations and death. A substantial proportion of asthma patients have poor asthma control, and a concurrent COPD diagnosis often increases disease burden. The
Externí odkaz:
https://doaj.org/article/0ed0880578a04906994836de545bd833
Autor:
Peter Lange, Nina Skavlan Godtfredsen, Beata Olejnicka, Bo-Anders Paradis, Dan Curiac, Sjur Humerfelt, Gunilla Telg, Helene Nordahl Christensen, Magnus Alexander Bitsch, Elisabeth Wreford Andersen, Leif Bjermer
Publikováno v:
European Clinical Respiratory Journal, Vol 3, Iss 0, Pp 1-11 (2016)
Introduction: Chronic obstructive pulmonary disease (COPD) is a progressive disease with symptoms that can have a major impact on patients’ physical health. The aim of this study was to evaluate quality of life (QoL), symptom severity and dyspnoea
Externí odkaz:
https://doaj.org/article/3024ec090c024e6294c2a6b57a5e65f7
Publikováno v:
ERJ Open Research. :00722-2022
BackgroundShort-acting beta-2-agonist (SABA) overuse has been associated with an increased risk of exacerbations in asthma; however, less is known about SABA use in chronic obstructive pulmonary disease (COPD). Our aim was to describe SABA use and in